SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
4.830
+0.230 (5.00%)
Feb 6, 2026, 12:00 PM EST - Market open
SOPHiA GENETICS Revenue
SOPHiA GENETICS had revenue of $19.46M in the quarter ending September 30, 2025, with 22.77% growth. This brings the company's revenue in the last twelve months to $73.30M, up 13.66% year-over-year. In the year 2024, SOPHiA GENETICS had annual revenue of $65.17M with 4.49% growth.
Revenue (ttm)
$73.30M
Revenue Growth
+13.66%
P/S Ratio
4.21
Revenue / Employee
$173,279
Employees
423
Market Cap
327.70M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 65.17M | 2.80M | 4.49% |
| Dec 31, 2023 | 62.37M | 14.81M | 31.14% |
| Dec 31, 2022 | 47.56M | 7.11M | 17.58% |
| Dec 31, 2021 | 40.45M | 12.05M | 42.43% |
| Dec 31, 2020 | 28.40M | 3.04M | 11.98% |
| Dec 31, 2019 | 25.36M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Evolent Health | 2.05B |
| Claritev | 951.00M |
| TruBridge | 347.27M |
| Definitive Healthcare | 242.28M |
| Weave Communications | 229.79M |
| So-Young International | 201.13M |
| Spok Holdings | 139.74M |
| National Research | 137.39M |
SOPH News
- 25 days ago - SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan - PRNewsWire
- 4 weeks ago - SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology - PRNewsWire
- 3 months ago - SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision Medicine - PRNewsWire
- 3 months ago - SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine - PRNewsWire
- 3 months ago - SOPHiA GENETICS SA (SOPH) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance - PRNewsWire
- 3 months ago - SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025 - PRNewsWire
- 4 months ago - A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan - PRNewsWire